Pain RSS Page 5

Filtered By:
Vaccination: Covid Vaccine

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 1865 results found since Jan 2013.

The most common gastrointestinal alterations in patients with post-COVID syndrome
CONCLUSION: We identified female gender, obesity, cardiovascular diseases, cancer, hypertension and diabetes as major risk factors of post-COVID syndrome. Vaccinated status may prevent post-COVID gastrointestinal symptoms. Orv Hetil. 2023; 164(31): 1206-1212.PMID:37543972 | DOI:10.1556/650.2023.32839
Source: Orvosi Hetilap - August 6, 2023 Category: General Medicine Authors: Kata Angyal Anna Mandula Tajthy B álint Drácz P ál Miheller Mikl ós Horváth Hajnal Sz ékely Veronika Papp Di ána Czompa Attila Szij ártó Kl ára Werling Source Type: research

Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study
CONCLUSION: Our study revealed that most side effects reported were mild in severity and self-limiting. Increasing the public's awareness of the nature of the vaccine's side effects would reduce the misinformation and improve the public's trust in vaccines. Larger studies to evaluate rare and serious adverse events and long-term side effects are needed, so people can have sufficient information and understanding before making an informed consent which is essential for vaccination.PMID:37544017 | PMC:PMC10405764 | DOI:10.1080/07853890.2023.2241351
Source: Annals of Medicine - August 6, 2023 Category: Internal Medicine Authors: Michel Najjar Sara Albuaini Mohammad Fadel Fatema Mohsen Data Collection Group Source Type: research

Henoch –schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report
ConclusionsOur results suggest that the immune response elicited by SARS-CoV2 vaccine or infection could play a role in the development of HSP. Current research suggests a possible role of IgA in immune hyperactivation, highlighted by early seroconversion to IgA found in some COVID-19 patients who develop IgA vasculitis.
Source: Internal and Emergency Medicine - July 27, 2023 Category: Emergency Medicine Source Type: research

Antiplatelet agents for the treatment of adults with COVID-19
CONCLUSIONS: In people with confirmed or suspected COVID-19 and moderate to severe disease, we found moderate-certainty evidence that antiplatelets probably result in little to no difference in 28-day mortality, clinical worsening or improvement, but probably result in a slight reduction in thrombotic events. They probably increase the occurrence of major bleeding events. Low-certainty evidence suggests that antiplatelets may result in a slight increase in serious adverse events. In people with confirmed COVID-19 and mild symptoms, we found low-certainty evidence that antiplatelets may result in little to no difference in ...
Source: Pain Physician - July 25, 2023 Category: Anesthesiology Authors: Anna-Lena Fischer Sarah Messer Rachel Riera Ana Luiza C Martimbianco Miriam Stegemann Lise J Estcourt Stephanie Weibel Ina Monsef Marike Andreas Rafael L Pacheco Nicole Skoetz Source Type: research

Difference Between COVID-19 Alpha Variant B.1.1.7 and the Original Virus in Gastrointestinal Symptoms and Mortality: Does a Negative Correlation Exist?
CONCLUSIONS: Thirty-day mortality and in-hospital mortality rates were 1.84 and 1.64 times higher from 6 November 2020 to 15 January 2021, the alpha variant, and in negative correlation with gastrointestinal symptoms.PMID:37461168
Source: The Israel Medical Association Journal - July 18, 2023 Category: General Medicine Authors: Yaron Niv Michael Kuniavsky Olga Bronshtein Nethanel Goldschmidt Shuli Hanhart Alexander Konson Hannah Mahalla Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20